The prevalence of HNPP has been reported to be at least 16 per 100,000.[1] The age of onset in this case was less than 20 years, which may be related to the differences in the expression of the PMP22 gene in different ethnic populations,[2] which requires further analysis. This evidence concerns the gene PMP22 and hereditary neuropathy with liability to pressure palsies.